This report focuses on an overview of Phase I–III clinical trials that initiated in 2022 across all therapeutic areas, as well as in-depth analyses into the key diseases, players, and geographies that impact the pharmaceutical industry.
This report focuses on an overview of Phase I–III clinical trials that initiated in 2022 across all therapeutic areas, as well as in-depth analyses into the key diseases, players, and geographies that impact the pharmaceutical industry.